Cough and Cold Preparations
Showing posts with label Cough and Cold Preparations. Show all posts
Showing posts with label Cough and Cold Preparations. Show all posts

Bisolvon

10:30 AM Add Comment
Bisolvon
Bisolvon®
Bromhexine HCl

Composition
Each tablet contains Bromhexine HCl 8 mg
5 ml elixir contains Bromhexine HCl 4 mg
(containing ethyl alcohol 3.72% v/v)

Properties
Bromhexine is a synthetic derivative of the herbal active ingredient vasicine.
Preclinically, it has been shown to increase the proportion of serous bronchial secretion. Bromhexine enhances mucus transport by reducing mucus viscosity and by activating the ciliated epithelium (mucociliary clearance).

In clinical studies. Bromhexine showed a secretolytic and secretomotor effect in the bronchial tract area, which facilitates expectoration and eases cough.

Indication
BISOLVON acts as a mucolytic to facilitate productive cough.

Dosage
Tablet
Adults and children › 10 years : 3 x 1 tablet dally
Children 5 - 10 years : 3 x 1/2 tablet daily
Children 2-5 years : 2 x 1/2 tablet daily

Elixir
Adults and children ›10years : 3 x 10 ml daily
Children 5-10 years : 3 x 5 ml daily
Children 2-5 years : 2 x 5 ml daily
Or according to doctor’s prescription.

Special Precautions
As with other drugs, it is advisable to avoid using it during the first trimester of pregnancy and lactation. BISOLVON should be used with caution in patients with gastric ulcers.

Pregnancy and Lactation
Available preclinical studies as well as clinical experience to date have shown no evidence of ill-effects during pregnancy. Nonetheless, the usual precautions regarding the use of drugs during pregnancy, especially during the first trimester, should be observed.
The drug is expected to enter breast milk and thus should be avoided during lactation.

Side Effects
BISOLVON is generally well tolerated. Diarrhoea, nausea, vomiting and other mild gastro-intestinal side effects have been reported. Allergic reactions including skin rashes, urticaria, bronchospasm, angio-oedema, and anaphylaxis have also been reported.

Contra-indications
BISOLVON should not be used in patients known to be hypersensitive to Bromhexine or other components of the formulations.

Interactions
Administration of Bromhexine together with antibiotics (Amoxicilline, Cefuroxime, Doxycycline) leads to higher antibiotic concentration in the lung tissue.

Overdose
No symptoms of overdose have been reported in man to date. If they occur, symptomatic treatment should be provided.

Availability
Tablet 8 mg
Box contains 10 strips of 10 tablets Reg. No. DTL0133700410A1
Box contains 10 catch cover of 4 tablets Reg. No. DTL0133700410A1

Elixir 4 mg/5 ml
Bottle of 60 ml Reg. No. DTL0133700534A1
Bottle of 125 ml Reg. No. DTL0133700534A1

Manufactured by:
PT. Boehringer Ingelheim Indonesia
Bogor, Indonesia

Under license from:
Boehringer Ingelheim International GmbH
Ingelheim am Rhein
Germany

Store in temperature 25-30°C, in a well-closed container.
Store in a safe place, out of the reach of children.

Bisolvon Flu

3:05 AM Add Comment
Bisolvon Flu
Bromhexine HCl, Paracetamol, Chlorpheniramine maleate, Phenylephrine HCl
For Flu and Cough

Composition
5 ml syrup contains :
Bromhexine hydrochloride 4 mg
Paracetamol 150 mg
Chlorpheniramine maleate 2 mg
Phenylephrine hydrochloride 5 mg

Excipients
Sodium benzoate, Aspartame, Sodium saccharine, Disodium edetate dihydrate, Tartaric acid, Peppermint, FD & C Yellow No.6, FD & C Blue No.l, Glycerol 100%, Sodium Carboxymethycellulose, Sorbitol 70%, Pufified water, PEG 1450, Propylene glycol, Menthol.

Properties
BISOLVON FLU is a combination of the secretolytic agent Bromhexine hydrochloride with analgesic-antipyretic (Paracetamol), antihistamine (Chlorpheniramine maleate) and decongestant (Phenylephrine).

Bromhexine is a synthetic derivative of the herbal active ingredient vasicine.
Preclinically, it has been shown to increase The proportion of serous bronchial secretion. Bromhexine enhances mucus transport by reducing mucus viscosity and
by activating the ciliated epithelium (mucociliary clearance).

In clinical studies, Bromhexine showed a secretolytic and secretornotor effect in the bronchial tract area, which facilitates expectoration and eases cough.

Paracetamol is an analgesic-antipyretic used ir temporary relief of headache and reduction of fever. Paracetamol is a clinically proven analgesic/antipyretic.
Paracetamol produces analgesia by elevation of the pain threshold and antipyresis through action on the hypothalamic heat regulating center.

Chlorpheniramine maleate is an alkylamine derivative antihistamin.

Phenylephrine HCL Is a decongestant for the symptomatic relief of nasal congestion and to ease breathlessness.

Indications
To relieve flu symptoms such as fever, headache, nasal congestion and sneezing following by cough.

Dosage and Administration
Adults and children over 12 years : 10 ml 3 times daily
Children 6 -12 years : 5 ml 3 times dally
Children under6years : on doctor's recommendation

Special Warning and Precautions
  • See Box Warning.
  • Caution in usage for patients with liver dysfunction, renal dysfunction, glaucoma, prostate hypertrophy hyperthyroid, and urinary retention. Caution in concomitant administration with other CNS depressants.
  • Phenylephrina may cause a prolonged rise in blood pressure. It Induces tachycardia or reflex bradycardia and should therefore be avoided in severe hyperthyroidism and used with caution in severe Ischemic heart disease. Hypertension and hypertension with pulmonary oedema have been described in infants.
  • Use with caution when driving a motor vehicle or operating machinery.
  • Not recommended for children under 6 years old, women who are pregnant or in lactation period, unless under doctor's recommendation.
  • Use with caution when taking this drug together with sedatives and tranquilizers.
  • Avoid alcoholic beverages while taking this product. Caution must be considered in patients who consume alcohol since this may increase th6 risk of liver dysfunction.
  • There have been very rare reports of severe skin lesions such as Stevens Johnson syndrome and Lyell's syndrome in temporal association with the administration of mucolytic substances such as Bromhexine. Mostly this could be explained by the severity of the underlying disease or concomitant medication. If new skin or mucosal lesions occur, medical advice should be sought immediately and treatment with Bromhexine discontinued as a precaution.
Contraindications
  • See Box Warning.
  • See Special Warnings and Precautions.
  • Patients with hypersensitivity with any component of this product.
  • Patients with severe liver dysfunction.
  • Patients with cardiac dysfunction and diabetes mellitus.
Side Effects
  • Drowsiness, gastro-intestinal disturbances (diarrhoea, nausea, vomiting), headache, insomnia, nervousness, tremor, tachicardia, ventriculary arrythmia, dry mouth, palpitations, difficulties in urination.
  • Allergic reactions including skin rashes, urticaria, bronchospasm, angio-oedema and anaphylaxis have also been reported.
  • Long term usage of paracetamol in high doses can cause liver damage.
Interactions
  • Not recommended to be given concomitantly with MAO inhibitor depressants, or within 2 weeks of stopping such therapy.
  • Administration of Bromhexine together with antibiotics (Amoxicillin, Cefuroxime, Eryhtromycin, Doxycycline) leads to higher antibiotic concentration.
  • Chlorpheniramine maleate has been reported to be incompatible with Calcium chloride, Kanamycin sulfate, Noradrenaline acid tartrate, Pentobarbital sodium and Meglumine adipidone.
  • Phenylephrine is stated to be incompatible with the local anaesthetic Butacaine.
Presentation
Bottle of 60 ml
Reg. No. DTL0733703837A1

Manufactured by:
PT. Boehringer Ingelheim Indonesia
Bogor, Indonesia

Under license from:
Boehringer Ingelheim International GmbH.
ingelheim am Rhein
Germany



  • Do not use for patients who are sensitive to other sympathomimetic drugs (e.g. Ephedrine, Phenylpropanolamine, Pseudoephedrine), who has severe high blood pressure and who are taking MAO inhibitor depressants.
  • Do not exceed the recommended dose.
  • Caution for patients who have hypertension or increasing blood pressure or stroke, such as overweight patients or elderly.
  • Consult the physicians or healthcare centre if the symptoms do not improve within 3 days.
  • Stop use if getting sleepless, dizzy or increasing heart rate.

Store in temperature 25-30°C, in a well-dosed container.
Store in a save place, out of the reach of children.



Subscribe to: Posts (Atom)